Millennium Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Millennium Management’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-851,735	Closed	-$5.68M	–	6720
2023 Q3	$5.68M	Buy	+851,735	New	+$7.08M	﹤0.01%	2586
2023 Q2	–	Sell	-290,618	Closed	-$2.11M	–	6913
2023 Q1	$2.11M	Sell	290,618 -290,272	-50%	-$2.15M	﹤0.01%	3388
2022 Q4	$4.24M	Buy	580,890 +220,029	+61%	+$1.63M	﹤0.01%	2957
2022 Q3	$2.79M	Buy	+360,861	New	+$3.06M	﹤0.01%	3455
2022 Q2	–	Sell	-588,075	Closed	-$4.69M	–	7703
2022 Q1	$4.69M	Buy	588,075 +563,888	+2,331%	+$3.58M	﹤0.01%	3007
2021 Q4	$135K	Buy	+24,187	New	+$181K	﹤0.01%	6124

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Millennium Management's PNT Position: Q4 2023 in Review

Millennium Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 851,735 shares — an estimated $5.68M sold.

Millennium Management first reported a position in PNT in Q4 2021 and held it in 6 quarters. The position peaked at $5.68M in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Millennium Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Millennium Management sold 851,735 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $5.68M.
Millennium Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Millennium Management's POINT Biopharma Global Inc. Common Stock position peaked at $5.68M in Q3 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.